The histopathological diagnosis of malignant mesothelioma v. pulmonary adenocarcinoma: reproducibility of the histopathological diagnosis.
In a randomized design we examined the interobserver variation in the histopathological diagnosis of adenocarcinoma of the lung and malignant mesothelioma. In three rounds, three pathologists assessed slides from 42 tumours originally diagnosed as adenocarcinomas, malignant mesotheliomas or benign lesions in the pleura. In the first round the assessments were made on haematoxylin and eosin (H & E) stained sections; in the second, on H & E sections plus sections stained with histochemical mucin stains; and in the final round, the diagnoses were made on H & E sections and sections stained with a panel of antibodies against various antigens (cytokeratin, EMA, CEA, Ber-EP4, B72.3, Leu-M1, vimentin and S-100 protein) said to be of value in the differential diagnosis. The overall interobserver agreements for the three rounds were 0.659, 0.802 and 0.817; the kappa values were 0.461, 0.681 and 0.690. It is concluded that differentiation between adenocarcinoma of the lung and malignant mesothelioma should be made on sections stained with H & E and mucin and/or immunohistochemical staining reactions, including antibodies against B72.3, Ber-EP4 and CEA.
Skov
B G
BG
Department of Pathology, KAS Glostrup, Denmark.
Lauritzen
A F
AF
Hirsch
F
F
Nielsen
H W
HW
D000230:Adenocarcinoma / Q000175:diagnosis / Q000276:immunology / Q000473:pathology*; D000951:Antigens, Neoplasm / Q000032:analysis; D003627:Data Interpretation, Statistical; D003937:Diagnosis, Differential; D006801:Humans; D007124:Immunoenzyme Techniques; D008175:Lung Neoplasms / Q000175:diagnosis / Q000276:immunology / Q000473:pathology*; D008654:Mesothelioma / Q000175:diagnosis / Q000276:immunology / Q000473:pathology*; D015588:Observer Variation; D010997:Pleural Neoplasms / Q000175:diagnosis / Q000276:immunology / Q000473:pathology; D011897:Random Allocation; D015203:Reproducibility of Results
D000951:Antigens, Neoplasm